TY - JOUR
T1 - Evaluation of biological malignancy of primary lung adenocarcinoma using two-dimensional polyacrylamide gel electrophoresis
AU - Hirano, Takashi
AU - Takekawa, Hiromi
AU - Hiyoshi, Toshimitsu
AU - Taguchi, Fumiko
AU - Ohira, Tatsuo
AU - Ikeda, Norihiko
AU - Kawate, Norihiko
AU - Konaka, Chimori
AU - Ebihara, Yoshiro
AU - Kato, Harubumi
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2000/6
Y1 - 2000/6
N2 - Objective: The usefulness of two-dimensional polyacrylamide gel electrophoresis (2-DE) combined with non-enzymatic sample preparation technique of surgically resected primary lung adenocarcinoma was discussed in terms of tumor malignancy. Study Design: Measurement of clinical materials was successful in 70 patients with primary lung adenocarcinoma between 1994 and 1996. We estimated the expression levels of the polypeptides associated with histopathological type as previously described (i.e. polypeptides associated with adenocarcinoma, TA01 ~ 05; polypeptides associated with squamous cell lung carcinoma, TSq01~04; polypeptides associated with neuroendocrine tumor, TS01~04) and proliferating cell nuclear antigen (PCNA) on 2-DE gels at the same time. Based on these data, all adenocarcinoma cases were classified into two groups and we attempted to evaluate the relationship between histopathological factors and prognosis in both groups. Results: We classified 26 cases (37.1%) as adenocarcinoma case with a typical 2-DE pattern and 44 cases (62.9%) as aadenocarcinoma with an atypical 2-DE pattern. The 2-year disease-free survival rates were 69.2% and 27.1% in typical cases and atypical cases, respectively, showing a statistically significant difference (p=0.0011). In stage I cases there was also a statistically significant difference (3-year-disease-free survival rate: typical cases, 94.1%; atypical cases, 46.7%; p = 0.0030). Conclusion: There is a strong possibility that 2DE evaluation may reflect biological malignancy of surgically resected primary lung adenocarcinoma.
AB - Objective: The usefulness of two-dimensional polyacrylamide gel electrophoresis (2-DE) combined with non-enzymatic sample preparation technique of surgically resected primary lung adenocarcinoma was discussed in terms of tumor malignancy. Study Design: Measurement of clinical materials was successful in 70 patients with primary lung adenocarcinoma between 1994 and 1996. We estimated the expression levels of the polypeptides associated with histopathological type as previously described (i.e. polypeptides associated with adenocarcinoma, TA01 ~ 05; polypeptides associated with squamous cell lung carcinoma, TSq01~04; polypeptides associated with neuroendocrine tumor, TS01~04) and proliferating cell nuclear antigen (PCNA) on 2-DE gels at the same time. Based on these data, all adenocarcinoma cases were classified into two groups and we attempted to evaluate the relationship between histopathological factors and prognosis in both groups. Results: We classified 26 cases (37.1%) as adenocarcinoma case with a typical 2-DE pattern and 44 cases (62.9%) as aadenocarcinoma with an atypical 2-DE pattern. The 2-year disease-free survival rates were 69.2% and 27.1% in typical cases and atypical cases, respectively, showing a statistically significant difference (p=0.0011). In stage I cases there was also a statistically significant difference (3-year-disease-free survival rate: typical cases, 94.1%; atypical cases, 46.7%; p = 0.0030). Conclusion: There is a strong possibility that 2DE evaluation may reflect biological malignancy of surgically resected primary lung adenocarcinoma.
KW - Biological malignancy
KW - Disease free survival rate
KW - Primary lung adenocarcinoma
KW - Two-dimensional polyacrylamide gel electrophoresis
UR - http://www.scopus.com/inward/record.url?scp=0033883467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033883467&partnerID=8YFLogxK
U2 - 10.2482/haigan.40.195
DO - 10.2482/haigan.40.195
M3 - Article
AN - SCOPUS:0033883467
VL - 40
SP - 195
EP - 200
JO - Japanese Journal of Lung Cancer
JF - Japanese Journal of Lung Cancer
SN - 0386-9628
IS - 3
ER -